ArticleBMJ open respiratory research2025
Occupational exposures in sarcoidosis: a protocol for a multicentre regional case-control study in the UK.
Article in BMJ open respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcoidosis is a multisystem granulomatous disease of unclear cause. An environmental trigger in a genetically susceptible individual resulting in immune dysregulation is suspected. More than 90% of cases of sarcoidosis involve the lungs, suggesting that inhaled environmental antigens contribute to the onset of disease. Many potential environmental antigens have been proposed to date, although equipoise persists concerning occupational exposures.The SANDSTONE study (Silica and Sarcoidosis: a study of Occupational Exposures) is the first UK-based study that investigates the association between occupational exposures and a diagnosis of pulmonary sarcoidosis, with particular focus on respirable crystalline silica, metal dusts, inorganic dusts and organic dusts. METHODS AND ANALYSIS: The SANDSTONE study is a multicentre case-control study recruiting participants from across the West Midlands region of the UK. The study targets recruiting n=174 participants in each group (1:1 case: control study). Case participants are patients diagnosed with pulmonary sarcoidosis since 2010 while control participants are recruited from NHS secondary care outpatient clinics. All participants will complete a semistructured interview to obtain full lifetime occupational and environmental exposure histories, with limited retrospective clinical data collected. The primary outcome measure is the OR of silica, metal dusts and other prespecified occupational exposure in pulmonary sarcoidosis. ETHICS AND DISSEMINATION: The study is sponsored by University Hospitals Birmingham NHS Foundation Trust and has received ethical approval from the Cambridge East Research Ethics Committee (19/EE/0360).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.